Lazari Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
74,300
+11,920
| +19% | +$289K | 0.68% | 29 |
|
|
2025
Q1 | $1.58M | Buy |
62,380
+30,151
| +94% | +$764K | 0.65% | 31 |
|
|
2024
Q4 | $855K | Buy |
32,229
+10,005
| +45% | +$265K | 0.34% | 47 |
|
|
2024
Q3 | $643K | Buy |
22,224
+3,329
| +18% | +$96.3K | 0.28% | 65 |
|
|
2024
Q2 | $529K | Buy |
18,895
+536
| +3% | +$15K | 0.24% | 71 |
|
|
2024
Q1 | $509K | Buy |
18,359
+10
| +0.1% | +$277 | 0.28% | 60 |
|
|
2023
Q4 | $528K | Sell |
18,349
-1,000
| -5% | -$28.8K | 0.3% | 58 |
|
|
2023
Q3 | $642K | Sell |
19,349
-3,322
| -15% | -$110K | 0.38% | 42 |
|
|
2023
Q2 | $832K | Buy |
+22,671
| New | +$832K | 0.47% | 39 |
|